The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 67, Issue 6, 2002, Pages 475-478

  Thomson, M ^a   Al Qattan, K K ^a   Al Sawan, S M ^a   Alnaqeeb, M A ^a   Khan, I ^a   Ali, M ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; CHOLESTEROL; GINGER EXTRACT; PROSTAGLANDIN E2; SODIUM CHLORIDE; THROMBOXANE B2; TRIACYLGLYCEROL; FIBRINOLYTIC AGENT; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG ISOLATION; DRUG USE; FEMALE; GINGER; NONHUMAN; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CHEMISTRY; MEDICINAL PLANT; ORAL DRUG ADMINISTRATION; SPRAGUE DAWLEY RAT; THROMBOCYTE;

ANIMALIA; ZINGIBER; ZINGIBER OFFICINALE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD PLATELETS; CHOLESTEROL; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBRINOLYTIC AGENTS; GINGER; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; RATS, SPRAGUE-DAWLEY; THROMBOXANE B2; TRIGLYCERIDES;

EID: 0036892995     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2002.0441     Document Type: Article

References (24)

1. Mustafa T., Srivastava K. C. Possible leads for arachidonic acid metabolism altering drugs from natural products. J Drug Dev 1990; 3: 47-60.
2. Botany 2000 - Asia Zingiberacai Workshop. Program and Abstracts. Prince of Songkla University, Hat Yai, Thailand, 15-18 October, 1991.
3. Govindarajan V. S. Ginger - Chemistry, technology and quality evaluation: Part 1. CRC Crit Rev Sci Nutr 1982; 17: 1-96.
4. Govindarajan V. S. Ginger - Chemistry, technology and quality evaluation: Part 2. CRC Crit Rev Sci Nutr 1982; 17: 189-258.
5. Suekawa M., Ishige A., Yusas K., Sudo K., Aburada M., Hosoya E. Pharmacological studies on ginger. 1. Pharmacological actions of pungent constituents, (6)-gingerol and (6)-shogaol. J Pharmacobiol Dyn 1984; 7: 836-848.
6. Srivastava K. C., Mustafa T. Spices: Antiplatelet activity and prostanoid metabolism. Prostaglandins Leukot Essent Fatty Acids 1989; 38: 255-266.
7. Srivastava K. C. Effects of aqueous extracts of onion, garlic and ginger on platelet aggregation and metabolism of arachidonic acid in the blood vascular system: In vitro study. Prostaglandins Leukot Med 1984; 13: 227-235.
8. Flynn D. L., Rafferty M. F., Bactor A. M. Inhibition of human neutrophil 5-lipooxygenase activity by gingerdione, shogoal, capsaicin and related pungent compounds. Prostaglandins Leukot Med 1986; 24: 195-198.
9. Srivastava K. C. Isolation and effects of some ginger components on platelet aggregation and eicosanoid biosynthesis. Prostaglandins Leukot Med 1986; 25: 187-198.
10. Dorso C. R., Levin R. I., Eldor A., Jaffe E. A., Weksler B. B. Chinese food and platelets. N Engl J Med 1980; 303: 756-757.
11. Srivastava K. C. Effect of onion and ginger consumption on platelet thromboxane production in humans. Prostaglandins Leukot Essent Fatty Acids 1989; 35: 183-185.
12. Verma S. K., Singh J., Khamsera R., Bordia A. Effect of ginger on platelet aggregation in man. Ind J Med Res 1993; 98: 240-242.
13. Lumb A. B. Effect of dried ginger on human platelet function. Thromb Haemostasis 1994; 7: 110-111.
14. Janssen PLTMK., Meyboom S., van Staveren W. A., Vegt F.de, Katan M. B. Consumption of ginger does not affect ex vivo platelet thromboxane production in humans. Eur J Clin Nutr 1996; 50: 772-774.
15. Srivastava K. C., Mustafa T. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hyp 1992; 39: 342-348.
16. Giri J., Devi T. K. S., Meerarani S. Effect of ginger on serum cholesterol levels. Ind J Nutr Dieter 1984; 21: 433-436.
17. Fuhrman B., Rosenblat M., Hayek T., Coleman R., Aviram M. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. J Nutr 2000; 130: 1124-1131.
18. Bordia A., Verma S. K., Srivastava K. C. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1997; 56: 379-384.
19. Srivastava K. C., Mustafa T. Ginger (Zingiber officinale) and rheumatic disorders. Med Hyp 1989; 29: 25-28.
20. Kiuchi F., Shibuya M., Sankawa U. Inhibitors of prostaglandins biosynthesis from ginger. Chem Pharm Bull (Japan) 1982; 30: 754-757.
21. Robinson D. R., McGuire M. B., Levine L. Prostaglandins in rheumatic diseases. Ann N Y Acad Sci 1975; 256: 318-329.
22. Lippiello Y., Yamamoto K., Robinson D., et al. Involvement of prostaglandins from rheumatoid synovium in inhibition of articular cartilage metabolism. Arthritis Rheum 1978; 21: 909-917.
23. Ali M., McDonald J. W. D. Reversible and irreversible inhibition of cyclooxygenase and serotonin release by non steroidal anti-inflammatory drugs. Thromb Res 1978; 13: 1057-1067.
24. Ali M., Zamecnik J., Cerskus A. L., Stoessel A. J., Barnett W. H., McDonald J. W. D. Synthesis of thromboxane B2 and prostaglandins by bovine gastric mucosal microsomes. Prostaglandins 1977; 14: 819-827.